Award

Blood pTau and GFAP dynamics in confirmed presymptomatic sporadic Alzheimer's Disease

Description: In Alzheimer’s disease (AD), pathological brain changes present decades before cognitive symptom onset. This presymptomatic AD stage has gained much attention for clinical trial entry as neuronal capacity can still be therapeutically preserved, preventing further cognitive decline. However, surprisingly little is known about the presymptomatic processes related to symptom onset in sporadic AD (sAD). My project aims to profile the presymptomatic phase by i) modelling the temporal dynamics within the decade before symptom onset, ii) linking these presymptomatic changes to the time-bound risk to develop clinical AD and iii) evaluating if presymptomatic changes predict future cognitive decline. I will take advantage of two novel blood-based biomarkers for AD, namely pTau and GFAP, and measure their levels along this presymptomatic trajectory in 204 sAD patients. Blood-based pTau and GFAP have already shown to reflect brain amyloid pathology. Nevertheless, to fully understand what these biomarkers in blood represent, I will now evaluate how pTau and GFAP relate to other pathological processes, namely neurofibrillary tangle (NFT) formation and synaptic loss in the AD brain. Besides, I will assess if the individual GFAP isoforms as well as their ratios provide additional information to total GFAP. Hence, my project will use blood-based biomarkers to gain insights in AD pathology with respect to symptom onset and key pathological processes in AD.
Funding type: fellowship
Funder scheme: FWO fellowships
Start date: 2021-11-01
End date: 2023-10-31
Field: Medicine
Funded outputs count: 4
Funder award ID: 11M0522N
OpenAlex ID: G5379295406
2025 · Steffi De Meyer, Elena R. Blujdea, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 12
2024 · Steffi De Meyer, Jolien M Schaeverbeke, et al. · Brain Communications · 31
2023 · Emma S. Luckett, Magdalena Zielonka, et al. · Alzheimer s Research & Therapy · 18
2022 · Steffi De Meyer, Jeroen Vanbrabant, et al. · Annals of Clinical and Translational Neurology · 33